Atlas Trials

Development and Clinical Application of ApoC3 Protein as a Predictive Biomarker for Insulin Resistance in Polycystic Ovary Syndrome

Clinical trial NCT07739953 · ACTIVE_NOT_RECRUITING

Trial details

NCT number
NCT07739953
Sponsor
Guangdong Women and Children Hospital
Status
ACTIVE_NOT_RECRUITING
Study type
OBSERVATIONAL
PCOS (Polycystic Ovary Syndrome)
Start date
2025-06-01
Primary completion
2026-12-31
Enrollment
200

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.